mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |